SS Innovations sells first surgical robotic system SSi Mantra in Middle East

Indian medtech company SS Innovations, developer of the “SSi Mantra,” a versatile and cost-effective surgical robotic system, has filled its first international order. The unit has been delivered to and will be installed in Aster Hospital, one of the premier hospitals in Dubai, United Arab Emirates, which is a part operated by Aster DM Healthcare Limited, a publicly-traded multinational for-profit hospital and healthcare that operates 32 hospitals and a network of other healthcare facilities in six countries.

SSi Mantra is the first surgical system to be made in India and one of the only systems in the world that was designed and built to be distinctly cost-effective with broad-spectrum surgical applications.

The system has been granted regulatory approval by the Indian Central Drugs Standard Control Organisation (CDSCO), India’s equivalent of the FDA, and has been clinically validated in India through use hundreds of times in more than 40 different types of surgical procedures, including those for cancer, head, spinal and heart surgeries. It is clinically validated in India. CDSCO approval also carries acceptance by up to 56 other countries and the company has begun the process of filing for FDA (American) and CE (European) approval.

The SSi Team designed its flagship technology, the SSi Mantra Surgical Robotic System, to have many superior and user-friendly features for the entire surgical team. This advanced system not only offers multi-specialty use, including cardiac surgery, but it also costs a fraction of the world’s best-selling surgical robot, which the company believes will enable many additional hospitals, physicians, and patients to benefit from the minimally invasive approach it offers.